FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to chemical-pharmaceutical industry, and can be used for correction of immune system disorders in pathological conditions associated with Th1-dependent immune response insufficiency. As an immunomodulatory drug stimulating Th1-dependent immune response, water-soluble polysaccharides of molecular weight 320 and 700 kDa recovered from compendial raw meadow clover are applied.
EFFECT: drug extends the range of the herbal immunomodulatory drugs, stimulates the production of interleukin-12 macrophages and tumour necrosis factor alpha.
4 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
MEDICATION POSSESSING IMMUNOMODULATING ACTIVITY | 2010 |
|
RU2423141C1 |
IMMUNOMODULATORY DRUG | 2011 |
|
RU2470656C1 |
MEANS OF IMMUNOMODULATING ACTIVITY | 2017 |
|
RU2657819C1 |
AGENT HAVING IMMUNOMODULATORY ACTIVITY | 2018 |
|
RU2697526C1 |
AGENT OF IMMUNOMODULATING ACTIVITY | 2007 |
|
RU2329821C1 |
AGENT OF IMMUNOMODULATING ACTIVITY | 2007 |
|
RU2337700C1 |
AGENT HAVING IMMUNOMODULATORY ACTIVITY | 2019 |
|
RU2734420C1 |
ANTIALLERGIC PREPARATION | 2008 |
|
RU2379047C1 |
AGENT OF HUMIC NATURE OF IMMUNOMODULATING ACTIVITY | 2017 |
|
RU2662094C1 |
IMMUNOMODULATING HUMIC AGENT | 2020 |
|
RU2756353C1 |
Authors
Dates
2011-06-20—Published
2010-06-07—Filed